Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Operating Expenses (2022)

Eton Pharmaceuticals' Other Operating Expenses history spans 1 years, with the latest figure at $1.1 million for Q1 2022.

  • On a quarterly basis, Other Operating Expenses changed N/A to $1.1 million in Q1 2022 year-over-year; TTM through Dec 2022 was $1.1 million, a N/A change, with the full-year FY2024 number at -$6.6 million, down 308.81% from a year prior.
  • Other Operating Expenses hit $1.1 million in Q1 2022 for Eton Pharmaceuticals.
  • Over the last five years, Other Operating Expenses for ETON hit a ceiling of $1.1 million in Q1 2022 and a floor of $1.1 million in Q1 2022.